191 related articles for article (PubMed ID: 24980554)
1. Cancer affects microRNA expression, release, and function in cardiac and skeletal muscle.
Chen D; Goswami CP; Burnett RM; Anjanappa M; Bhat-Nakshatri P; Muller W; Nakshatri H
Cancer Res; 2014 Aug; 74(16):4270-81. PubMed ID: 24980554
[TBL] [Abstract][Full Text] [Related]
2. Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage.
Zhu M; Yi M; Kim CH; Deng C; Li Y; Medina D; Stephens RM; Green JE
Genome Biol; 2011 Aug; 12(8):R77. PubMed ID: 21846369
[TBL] [Abstract][Full Text] [Related]
3. Aging-associated skeletal muscle defects in HER2/Neu transgenic mammary tumor model.
Wang R; Kumar B; Bhat-Nakshatri P; Prasad MS; Jacobsen MH; Ovalle G; Maguire C; Sandusky G; Trivedi T; Mohammad KS; Guise T; Penthala NR; Crooks PA; Liu J; Zimmers T; Nakshatri H
JCSM Rapid Commun; 2021; 4(1):24-39. PubMed ID: 33842876
[TBL] [Abstract][Full Text] [Related]
4. Modulation of tumor fatty acids, through overexpression or loss of thyroid hormone responsive protein spot 14 is associated with altered growth and metastasis.
Wellberg EA; Rudolph MC; Lewis AS; Padilla-Just N; Jedlicka P; Anderson SM
Breast Cancer Res; 2014 Dec; 16(6):481. PubMed ID: 25472762
[TBL] [Abstract][Full Text] [Related]
5. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
6. Hormonally Regulated Myogenic miR-486 Influences Sex-specific Differences in Cancer-induced Skeletal Muscle Defects.
Wang R; Bhat-Nakshatri P; Zhong X; Zimmers T; Nakshatri H
Endocrinology; 2021 Oct; 162(10):. PubMed ID: 34265069
[TBL] [Abstract][Full Text] [Related]
7. Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486.
Small EM; O'Rourke JR; Moresi V; Sutherland LB; McAnally J; Gerard RD; Richardson JA; Olson EN
Proc Natl Acad Sci U S A; 2010 Mar; 107(9):4218-23. PubMed ID: 20142475
[TBL] [Abstract][Full Text] [Related]
8. Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.
Otsuka Y; Oikawa T; Yoshino H; Hashimoto S; Handa H; Yamamoto H; Hashimoto A; Sabe H
Cell Commun Signal; 2018 Jan; 16(1):1. PubMed ID: 29329590
[TBL] [Abstract][Full Text] [Related]
9. Insertional mutagenesis in a HER2-positive breast cancer model reveals ERAS as a driver of cancer and therapy resistance.
Ikink GJ; Boer M; Bakker ERM; Vendel-Zwaagstra A; Klijn C; Ten Hoeve J; Jonkers J; Wessels LF; Hilkens J
Oncogene; 2018 Mar; 37(12):1594-1609. PubMed ID: 29326437
[TBL] [Abstract][Full Text] [Related]
10. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
11. Lack of fetuin-A (alpha2-HS-glycoprotein) reduces mammary tumor incidence and prolongs tumor latency via the transforming growth factor-beta signaling pathway in a mouse model of breast cancer.
Guillory B; Sakwe AM; Saria M; Thompson P; Adhiambo C; Koumangoye R; Ballard B; Binhazim A; Cone C; Jahanen-Dechent W; Ochieng J
Am J Pathol; 2010 Nov; 177(5):2635-44. PubMed ID: 20847285
[TBL] [Abstract][Full Text] [Related]
12. TNF-α and IGF1 modify the microRNA signature in skeletal muscle cell differentiation.
Meyer SU; Thirion C; Polesskaya A; Bauersachs S; Kaiser S; Krause S; Pfaffl MW
Cell Commun Signal; 2015 Jan; 13():4. PubMed ID: 25630602
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of metabolic-associated pathways in muscle of breast cancer patients: preclinical evaluation of interleukin-15 targeting fatigue.
Bohlen J; McLaughlin SL; Hazard-Jenkins H; Infante AM; Montgomery C; Davis M; Pistilli EE
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):701-714. PubMed ID: 29582584
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of myogenic microRNAs 1, 133, and 206 by inflammatory cytokines links inflammation and muscle degeneration in adult inflammatory myopathies.
Georgantas RW; Streicher K; Greenberg SA; Greenlees LM; Zhu W; Brohawn PZ; Higgs BW; Czapiga M; Morehouse CA; Amato A; Richman L; Jallal B; Yao Y; Ranade K
Arthritis Rheumatol; 2014 Apr; 66(4):1022-33. PubMed ID: 24757153
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of miR-489 derails mammary hierarchy structure and inhibits HER2/neu-induced tumorigenesis.
Patel Y; Soni M; Awgulewitsch A; Kern MJ; Liu S; Shah N; Singh UP; Chen H
Oncogene; 2019 Jan; 38(3):445-453. PubMed ID: 30104710
[TBL] [Abstract][Full Text] [Related]
16. Regulation of IRS1/Akt insulin signaling by microRNA-128a during myogenesis.
Motohashi N; Alexander MS; Shimizu-Motohashi Y; Myers JA; Kawahara G; Kunkel LM
J Cell Sci; 2013 Jun; 126(Pt 12):2678-91. PubMed ID: 23606743
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
[TBL] [Abstract][Full Text] [Related]
18. GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and β-catenin activity.
Maric G; Annis MG; MacDonald PA; Russo C; Perkins D; Siwak DR; Mills GB; Siegel PM
Oncogene; 2019 Jun; 38(26):5294-5307. PubMed ID: 30914799
[TBL] [Abstract][Full Text] [Related]
19. Temporal correlation between differentiation factor expression and microRNAs in Holstein bovine skeletal muscle.
Miretti S; Volpe MG; Martignani E; Accornero P; Baratta M
Animal; 2017 Feb; 11(2):227-235. PubMed ID: 27406318
[TBL] [Abstract][Full Text] [Related]
20. Attenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesis.
Novitskiy SV; Forrester E; Pickup MW; Gorska AE; Chytil A; Aakre M; Polosukhina D; Owens P; Yusupova DR; Zhao Z; Ye F; Shyr Y; Moses HL
Breast Cancer Res; 2014 Oct; 16(5):425. PubMed ID: 25280532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
